KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Boston Scientific (BSX) Research & Development (2016 - 2026)

Boston Scientific's Research & Development history spans 18 years, with the latest figure at $516.0 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 16.48% to $516.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.1 billion, a 25.59% increase, with the full-year FY2025 number at $2.1 billion, up 27.06% from a year prior.
  • Research & Development hit $516.0 million in Q1 2026 for Boston Scientific, down from $569.0 million in the prior quarter.
  • Over the last five years, Research & Development for BSX hit a ceiling of $569.0 million in Q4 2025 and a floor of $319.0 million in Q1 2022.
  • Historically, Research & Development has averaged $407.1 million across 5 years, with a median of $366.0 million in 2024.
  • Biggest five-year swings in Research & Development: grew 3.12% in 2022 and later surged 37.34% in 2025.
  • Tracing BSX's Research & Development over 5 years: stood at $330.0 million in 2022, then increased by 10.0% to $363.0 million in 2023, then rose by 26.45% to $459.0 million in 2024, then rose by 23.97% to $569.0 million in 2025, then dropped by 9.31% to $516.0 million in 2026.
  • Business Quant data shows Research & Development for BSX at $516.0 million in Q1 2026, $569.0 million in Q4 2025, and $514.0 million in Q3 2025.